July 17, 2017
Abbott and Bigfoot Biomedical have entered into an agreement to develop and commercialize diabetes management systems, integrating Abbott's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions.
Under the agreement, Abbott will supply glucose measurement sensors for all of Bigfoot's insulin delivery systems in the U.S. as the exclusive sensors for those systems...
February 15, 2017
Abbott Diabetes Care shared some real-world evidence this morning at the International Conference on Advanced Technologies & Treatments for Diabetes, bolstering clinical trial data about the effectiveness of the company's Freestyle Libre device line.
"We’re certainly committed to sharing as much information as is possible with our users and our health providers in order to be able to make...
September 28, 2016
Abbott has received FDA Clearance for its FreeStyle Libre Pro system, a key milestone in bringing the company's unique take on the continuous glucose monitor to the United States. In Europe, where the system has had CE Mark clearance since September 2014, there is both a prescription and over-the-counter version available and the latter is smartphone compatible.
"FreeStyle Libre Pro transforms...